CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company
SOLIGENIX, INC.
Sign in to watch- Ticker
- SNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411505029
- Phone
- 609-538-8200
- Business address
- 29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
- Former names
- SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
- 4 Insider Changes in Ownership
- 8-K Event Results of operations
- 10QSB Other 10QSB
- SB-2 Other SB-2
- REGDEX Other REGDEX
- 8-K Event Delisting notice
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Unregistered share sale · Other events
- 8-K Event Material agreement
- NT 10-K Other NT 10-K
- 10KSB Other 10KSB
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
Page 58 of 72 · 1,429 filings